Whole body vibration improves osseointegration by up-regulating osteoblastic activity but down-regulating osteoblast-mediated osteoclastogenesis via ERK1/2 pathway
Whole body vibration improves osseointegration by up-regulating osteoblastic activity but down-regulating osteoblast-mediated osteoclastogenesis via ERK1/2 pathway
复制标题
全身振动通过 ERK1/2 途径上调成骨细胞活性,但下调成骨细胞介导的破骨细胞生成,从而改善骨整合
DOI:
10.1016/j.bone.2014.09.026
复制
发表时间:
2015
期刊:
影响因子:
4.1
通讯作者:
Wang Huiming
中科院分区:
文献类型:
--
作者:
Zhou Yi;Guan Xiaoxu;Liu Tie;Wang Xinhua;Yu Mengfei;Yang Guoli;Wang Huiming
Due to the reduction in bone mass and deterioration in bone microarchitecture, osteoporosis is an important risk factor for impairing implant osseointegration. Recently, low-magnitude, high-frequency (LMHF) vibration (LM: < 1 ×g; HF: 20–90 Hz) has been shown to exhibit anabolic, but anti-resorptive effects on skeletal homeostasis. Therefore, we hypothesized that LMHF loading, in terms of whole body vibration (WBV), may improve implant fixation under osteoporotic status. In thein vivostudy, WBV treatment (magnitude: 0.3 g, frequency: 40 Hz, time: 30 min/12 h, 5 days/week) was applied after hydroxyapatite-coated titanium implants were inserted in the bilateral tibiae of ovariectomized rats. The bone mass and the osteospecific gene expressions were measured at 12 weeks post implantation. In thein vitrostudy, the cellular and molecular mechanisms underlying osteoblastic and osteoclastic activities were fully investigated using various experimental assays. Micro-CT examination showed that WBV could enhance osseointegration by improving microstructure parameters surrounding implants. WBV-regulated gene levels in favor of bone formation over resorption may be the reason for the favorable adaptive bone remolding on bone-implant surface. Thein vitrostudy showed that vibration (magnitude: 0.3 g, frequency: 40 Hz, time: 30 min/12 h) up-regulated osteoblast differentiation, matrix synthesis and mineralization. However, mechanically regulated osteoclastic activity was mainly through the effect on osteoblastic cells producing osteoclastogenesis-associated key soluble factors, including RANKL and M-CSF. Osteoblasts were therefore the direct target cells during the mechanotransduction process. The ERK1/2 pathway was demonstrated to play an essential role in vibration-induced enhancement of bone formation and decreased bone resorption. Our data suggests that WBV was a helpful non-pharmacological intervention for improving osseointegration under osteoporosis.